Advertisement

Advertisement

ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
Posted: 06/13/2022 | By: Kayci Reyer

Question 1 of 5

In some patients with acute myeloid leukemia, measurable residual disease is associated with:

Choose 1